Drug
Eniluracil clinical trials
Also written 776C85.
- studies test it
- 7
- open now
- 0
- in phase 3
- 1
- first study started
- 1998
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
7 studies that test it; most in 1998 (2)
| Year | Studies |
|---|---|
| 1998 | 2 |
| 1999 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 4
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 4
Processa Pharmaceuticals (2) · University of Alabama at Birmingham (1) · National Cancer Institute (NCI) (1) · SWOG Cancer Research Network (1) · West Virginia University (1) · Adherex Technologies, Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses eniluracil is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerTerminatedPhase 2Processa PharmaceuticalsNCT06568692Written as PCS6422 and capecitabine
- A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract TumorsCompletedPhase 1Processa PharmaceuticalsNCT04861987Written as PCS6422 and capecitabine
- Eniluracil Hand Foot SyndromeTerminatedPhase 1West Virginia UniversityNCT00827580Written as Eniluracil
- Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal CancerCompletedPhase 2University of Alabama at BirminghamNCT00004195Written as eniluracil
- Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal CancerCompletedPhase 3National Cancer Institute (NCI)NCT00003873Written as eniluracil
- Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast CancerStatus unknownPhase 2Adherex Technologies, Inc.NCT01231802Written as Eniluracil
- SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to FluorouracilCompletedPhase 2SWOG Cancer Research NetworkNCT00003254Written as ethynyluracil
Codes
What other systems call eniluracil · ClinicalTrials.gg INT003619
- MeSH (NLM) C073482eniluracilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2E2W0W5XIUENILURACILConfirmed FDA, NLM, Wikidata
- Wikidata Q27094456eniluracilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1773EniluracilOne source FDA
- DrugBank DB03516One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C073482 | eniluracil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2E2W0W5XIU | ENILURACIL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27094456 | eniluracil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1773 | Eniluracil | One source FDA |
| DrugBank | DB03516 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.